Literature DB >> 28634774

Learning from Synthetic Models of Extracellular Matrix; Differential Binding of Wild Type and Amyloidogenic Human Apolipoprotein A-I to Hydrogels Formed from Molecules Having Charges Similar to Those Found in Natural GAGs.

Silvana A Rosú1,2, Leandro Toledo3, Bruno F Urbano3, Susana A Sanchez3, Graciela C Calabrese4, M Alejandra Tricerri5,6.   

Abstract

Among other components of the extracellular matrix (ECM), glycoproteins and glycosaminoglycans (GAGs) have been strongly associated to the retention or misfolding of different proteins inducing the formation of deposits in amyloid diseases. The composition of these molecules is highly diverse and a key issue seems to be the equilibrium between physiological and pathological events. In order to have a model in which the composition of the matrix could be finely controlled, we designed and synthesized crosslinked hydrophilic polymers, the so-called hydrogels varying the amounts of negative charges and hydroxyl groups that are prevalent in GAGs. We checked and compared by fluorescence techniques the binding of human apolipoprotein A-I and a natural mutant involved in amyloidosis to the hydrogel scaffolds. Our results indicate that both proteins are highly retained as long as the negative charge increases, and in addition it was shown that the mutant is more retained than the Wt, indicating that the retention of specific proteins in the ECM could be part of the pathogenicity. These results show the importance of the use of these polymers as a model to get deep insight into the studies of proteins within macromolecules.

Entities:  

Keywords:  Amyloidosis; Extracellular matrix; Human apolipoprotein A-I; Synthetic hydrogels

Mesh:

Substances:

Year:  2017        PMID: 28634774     DOI: 10.1007/s10930-017-9728-8

Source DB:  PubMed          Journal:  Protein J        ISSN: 1572-3887            Impact factor:   2.371


  29 in total

1.  Quantification of beta-sheet amyloid fibril structures with thioflavin T.

Authors:  H LeVine
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease.

Authors:  M B Stokes; S Holler; Y Cui; K L Hudkins; F Eitner; A Fogo; C E Alpers
Journal:  Kidney Int       Date:  2000-02       Impact factor: 10.612

3.  Folding intermediates of the prion protein stabilized by hydrostatic pressure and low temperature.

Authors:  Samantha M Martins; Alex Chapeaurouge; Sérgio T Ferreira
Journal:  J Biol Chem       Date:  2003-10-02       Impact factor: 5.157

4.  In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis.

Authors:  Jin-Ping Li; Martha L Escobar Galvis; Feng Gong; Xiao Zhang; Eyal Zcharia; Shula Metzger; Israel Vlodavsky; Robert Kisilevsky; Ulf Lindahl
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-20       Impact factor: 11.205

5.  Atheroprotective remodelling of vascular dermatan sulphate proteoglycans in response to hypercholesterolaemia in a rat model.

Authors:  Roxana Oberkersch; Francesca Maccari; Alicia I Bravo; Nicola Volpi; Silvina Gazzaniga; Graciela C Calabrese
Journal:  Int J Exp Pathol       Date:  2014-03-07       Impact factor: 1.925

Review 6.  Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases.

Authors:  Javier Díaz-Nido; Francisco Wandosell; Jesús Avila
Journal:  Peptides       Date:  2002-07       Impact factor: 3.750

Review 7.  The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype.

Authors:  Michael G Kinsella; Steven L Bressler; Thomas N Wight
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2004       Impact factor: 1.807

8.  Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease.

Authors:  R Kisilevsky; L J Lemieux; P E Fraser; X Kong; P G Hultin; W A Szarek
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

Review 9.  Endothelial protection by high-density lipoproteins: from bench to bedside.

Authors:  Laura Calabresi; Monica Gomaraschi; Guido Franceschini
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-09-11       Impact factor: 8.311

10.  Human apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensity.

Authors:  Nahuel A Ramella; Guillermo R Schinella; Sergio T Ferreira; Eduardo D Prieto; María E Vela; José Luis Ríos; M Alejandra Tricerri; Omar J Rimoldi
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

View more
  1 in total

1.  Synthetic Sulfated Polymers Control Amyloid Aggregation of Ovine Prion Protein and Decrease Its Toxicity.

Authors:  Pavel Semenyuk; Diana Evstafyeva; Vladimir Izumrudov; Vladimir Muronetz
Journal:  Polymers (Basel)       Date:  2022-04-05       Impact factor: 4.329

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.